| MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2 R Das, PA Gregory, RC Fernandes, I Denis, Q Wang, SL Townley, ... Cancer research 77 (4), 1021-1034, 2017 | 113 | 2017 |
| Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer S Paltoglou, R Das, SL Townley, TE Hickey, GA Tarulli, I Coutinho, ... Cancer research 77 (13), 3417-3430, 2017 | 107 | 2017 |
| Nanoparticles produced by ring-opening metathesis polymerization using norbornenyl-poly (ethylene oxide) as a ligand-free generic platform for highly selective in vivo tumor … F Gueugnon, I Denis, D Pouliquen, F Collette, R Delatouche, V Héroguez, ... Biomacromolecules 14 (7), 2396-2402, 2013 | 47 | 2013 |
| Aurones as histone deacetylase inhibitors: identification of key features V Zwick, AO Chatzivasileiou, N Deschamps, M Roussaki, ... Bioorganic & medicinal chemistry letters 24 (23), 5497-5501, 2014 | 43 | 2014 |
| Histone deacetylase inhibitors delivery using nanoparticles with intrinsic passive tumor targeting properties for tumor therapy F El Bahhaj, I Denis, L Pichavant, R Delatouche, F Collette, C Linot, ... Theranostics 6 (6), 795, 2016 | 37 | 2016 |
| Vorinostat–polymer conjugate nanoparticles for acid-responsive delivery and passive tumor targeting I Denis, F El Bahhaj, F Collette, R Delatouche, F Gueugnon, D Pouliquen, ... Biomacromolecules 15 (12), 4534-4543, 2014 | 32 | 2014 |
| Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery I Denis, F El Bahhaj, F Collette, R Delatouche, F Gueugnon, D Pouliquen, ... European Journal of Medicinal Chemistry 95, 369-376, 2015 | 29 | 2015 |
| Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma I Denis, L Cellerin, M Gregoire, C Blanquart Oncotarget 5 (22), 11641, 2014 | 26 | 2014 |
| Design of pH responsive clickable prodrugs applied to histone deacetylase inhibitors: a new strategy for anticancer therapy R Delatouche, I Denis, M Grinda, F El Bahhaj, E Baucher, F Collette, ... European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 862-872, 2013 | 23 | 2013 |
| Androgen receptor signalling promotes a luminal phenotype in mammary epithelial cells GA Tarulli, G Laven-Law, M Shehata, KA Walters, IM Denis, MM Rahman, ... Journal of Mammary Gland Biology and Neoplasia 24, 99-108, 2019 | 7 | 2019 |
| A route to highly functionalized stereospecific trans-aminated aurones from 3-bromoflavones with aniline and N-phenylurea via a domino aza-Michael ring opening and cyclization … I Parveen, N Ahmed Synthesis 51 (04), 960-970, 2019 | 7 | 2019 |
| AR chromatin binding is reprogrammed in the absence of FOXA1 in ER-breast cancers I Denis, LA Selth, JLL Robinson, H Mohammed, T Carroll, GD Brown, ... Oncology Abstracts 1, 2019 | | 2019 |
| deacetylase inhibitors: A new strategy for anticancer therapy R Delatouche, I Denis, M Grinda, F El Bahhaj, E Baucher, F Collette, ... | | 2013 |
